Twenty years of operations throughout Europe
Medextens was established by Frederic Daoud in 1996 in Paris. It started operations in London in 2003.
Medextens focuses on the clinical and health economic assessment of medical technologies. We also have extensive experience in first-in-man studies and new indication studies. Our scope includes medical devices, in vitro diagnostic systems, drug-device combinations and biological-device combinations.
Medextens is dedicated to client success. We respect confidentiality and do not take on projects that cause a conflict of interests. We cooperate with other consulting firms on an ad hoc basis providing the cooperation has been approved by the client beforehand. We follow strictly laws and regulations.
Medextens has conducted small and large-scale assignments in most European countries as well as in the United States and Canada.